Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine

prnewswireDecember 14, 2020

Tag: ACTT-2 , COVID-19 , Baricitinib , Eli Lilly , Incyte

PharmaSources Customer Service